Open AccessMDR1 Haplotypes and G2677T/A Polymorphism Predict Imatinib Response in Tunisian Patients with Chronic Myeloid Leukemia
Author(s) -
Mariam Ammar,
Sonia Ktari,
Moez Medhaffar,
H. Ghozzi,
Moez Elloumi,
A. Hammami,
Khaled Zeghal,
Lobna Ben Mahmoud
Publication year - 2022
Publication title -
journal of biosciences and medicines
Language(s) - English
Resource type - Journals
eISSN - 2327-509X
pISSN - 2327-5081
DOI - 10.4236/jbm.2022.109009
Subject(s) - myeloid leukemia , genotype , imatinib , genotyping , haplotype , imatinib mesylate , medicine , single nucleotide polymorphism , allele , pharmacogenetics , oncology , gastroenterology , immunology , biology , gene , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom